載入...
Hyponatraemia secondary to nivolumab-induced primary adrenal failure
Checkpoint inhibitors, such as ipilimumab and pembrolizumab, have transformed the prognosis for patients with advanced malignant melanoma and squamous non-small-cell lung cancer, and their use will only expand as experience is gained in a variety of other malignancies, for instance, renal and lympho...
Na minha lista:
Main Authors: | , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Bioscientifica
2016-11-01
|
叢編: | Endocrinology, Diabetes & Metabolism Case Reports |
在線閱讀: | https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-16-0108 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|